Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Published 2014 View Full Article

Authors

Keywords

Journal

CLINICAL CANCER RESEARCH

Volume 20, Issue 7, Pages 1884-1890

Publisher

American Association for Cancer Research (AACR)

Online

2014-01-30

DOI

10.1158/1078-0432.ccr-13-2649

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

CLINICAL CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Become a Peeref-certified reviewer